Tokyo Tape
Sign in
← PeptiDream

Annual report

4587.TEDINET S100T61M
Period2023-01-01 → 2023-12-31
Filed2024-03-28
StandardIFRS
ConsolidatedYes
Data checks18 of 22 passed

Amended by S100UF9P (2024-09-25).

Key figures · 162
MetricValuePeriodScopeSource row
Revenue¥28.7bn2023-01-01 → 2023-12-31Cons.Revenue IFRS
Revenue¥26.9bn2022-01-01 → 2022-12-31Cons.Revenue IFRS
Revenue¥9.4bn2021-01-01 → 2021-12-31dCons.Revenue IFRS (5-year summary)
Operating income¥6.8bn2023-01-01 → 2023-12-31Cons.Operating profit loss IFRS
Operating income¥9.0bn2022-01-01 → 2022-12-31Cons.Operating profit loss IFRS
Ordinary income¥8.1bn2022-01-01 → 2022-12-31Cons.Ordinary income loss (5-year summary)
Profit before tax¥4.4bn2023-01-01 → 2023-12-31Cons.Profit loss before tax IFRS
Profit before tax¥6.7bn2022-01-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax¥3.8bn2021-01-01 → 2021-12-31dCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)¥3.0bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥7.6bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥6.6bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.6bn2021-01-01 → 2021-12-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income¥3.0bn2023-01-01 → 2023-12-31Cons.Profit loss IFRS
Net income¥7.6bn2022-01-01 → 2022-12-31Cons.Profit loss IFRS
Total assets¥69.5bnat 2023-12-31Cons.Assets IFRS
Total assets¥63.9bnat 2022-12-31Cons.Assets IFRS
Total assets¥60.1bnat 2022-12-31Cons.Total assets (5-year summary)
Total assets¥27.0bnat 2021-12-31dCons.Total assets IFRS (5-year summary)
Total assets¥26.1bnat 2020-12-31dCons.Total assets IFRS (5-year summary)
Total liabilities¥29.1bnat 2023-12-31Cons.Liabilities IFRS
Total liabilities¥31.8bnat 2022-12-31Cons.Liabilities IFRS
Net assets / equity¥40.3bnat 2023-12-31Cons.Equity IFRS
Net assets / equity¥32.0bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥30.5bnat 2022-12-31Cons.Net assets (5-year summary)
Net assets / equity¥25.4bnat 2021-12-31dCons.Equity IFRS
Equity (owners)¥40.3bnat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥32.0bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥25.4bnat 2021-12-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥21.3bnat 2020-12-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥19.5bnat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥5.2bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥11.7bnat 2021-12-31dCons.Cash and cash equivalents IFRS
Cash & equivalents¥7.1bnat 2020-12-31dCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥12.4bn2023-01-01 → 2023-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow−¥83m2022-01-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow−¥350m2022-01-01 → 2022-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥6.7bn2021-01-01 → 2021-12-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow¥1.3bn2023-01-01 → 2023-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥27.4bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥27.3bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥2.3bn2021-01-01 → 2021-12-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow¥264m2023-01-01 → 2023-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥20.8bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥21.0bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥66m2021-01-01 → 2021-12-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥23.412023-01-01 → 2023-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥58.192022-01-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥51.132022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥19.962021-01-01 → 2021-12-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥23.382023-01-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥58.142022-01-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥19.812021-01-01 → 2021-12-31dCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥311.16at 2023-12-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥234.8at 2022-12-31Cons.Net assets per share (5-year summary)
Net assets per share¥246.63at 2022-12-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥195.1at 2021-12-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥168.1at 2020-12-31dCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio58.1%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio50.5%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio50.2%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio93.8%at 2021-12-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio81.4%at 2020-12-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE8.4%2023-01-01 → 2023-12-31Cons.Rate of return on equity IFRS (5-year summary)
ROE24.4%2022-01-01 → 2022-12-31Cons.Rate of return on equity (5-year summary)
ROE26.3%2022-01-01 → 2022-12-31Cons.Rate of return on equity IFRS (5-year summary)
ROE11.0%2021-01-01 → 2021-12-31dCons.Rate of return on equity IFRS (5-year summary)
Employees603at 2023-12-31Cons.Number of employees
Employees569at 2022-12-31Cons.Number of employees
Employees141at 2021-12-31dCons.Number of employees
Employees128at 2020-12-31dCons.Number of employees
Revenue¥12.7bn2023-01-01 → 2023-12-31StandaloneNet sales
Revenue¥15.4bn2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥9.4bn2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Revenue¥11.7bn2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Revenue¥1.0bn2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Revenue¥7.2bn2018-01-01 → 2018-12-31dStandaloneNet sales (5-year summary)
Operating income¥6.4bn2023-01-01 → 2023-12-31StandaloneOperating income
Operating income¥9.1bn2022-01-01 → 2022-12-31StandaloneOperating income
Ordinary income¥6.4bn2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income¥8.8bn2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income¥4.8bn2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥7.0bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥707m2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥3.8bn2018-01-01 → 2018-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥7.0bn2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Profit before tax¥6.9bn2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Net income¥5.8bn2023-01-01 → 2023-12-31StandaloneProfit loss
Net income¥4.3bn2022-01-01 → 2022-12-31StandaloneProfit loss
Net income¥3.6bn2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income¥4.4bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Net income−¥488m2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Net income¥2.8bn2018-01-01 → 2018-12-31dStandaloneNet income loss (5-year summary)
Total assets¥68.2bnat 2023-12-31StandaloneAssets
Total assets¥55.2bnat 2022-12-31StandaloneAssets
Total assets¥26.6bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥26.3bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥17.8bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total assets¥20.0bnat 2018-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥27.6bnat 2023-12-31StandaloneLiabilities
Total liabilities¥25.8bnat 2022-12-31StandaloneLiabilities
Net assets / equity¥40.6bnat 2023-12-31StandaloneNet assets
Net assets / equity¥29.4bnat 2022-12-31StandaloneNet assets
Net assets / equity¥25.0bnat 2021-12-31dStandaloneNet assets
Net assets / equity¥21.2bnat 2020-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥17.0bnat 2019-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥17.4bnat 2018-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥16.2bnat 2023-12-31StandaloneCash and deposits
Cash and deposits¥847mat 2022-12-31StandaloneCash and deposits
Cash & equivalents¥11.7bnat 2021-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥7.1bnat 2020-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥7.0bnat 2019-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥6.9bnat 2018-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥6.7bn2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.7bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥242m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥4.5bn2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥2.3bn2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.2bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥138m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.3bn2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥66m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥237m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥29m2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥44.852023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥33.112022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥27.982021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥35.42020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-3.92019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥22.422018-01-01 → 2018-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥27.782021-01-01 → 2021-12-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥34.262020-01-01 → 2020-12-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥21.332018-01-01 → 2018-12-31dStandaloneDiluted earnings per share (5-year summary)
Net assets per share¥312.89at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥226.48at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥192.39at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥168.1at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥134.97at 2019-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥138.73at 2018-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio59.5%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio53.2%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio93.8%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio80.5%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio94.8%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio86.6%at 2018-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE16.6%2023-01-01 → 2023-12-31StandaloneRate of return on equity (5-year summary)
ROE15.8%2022-01-01 → 2022-12-31StandaloneRate of return on equity (5-year summary)
ROE15.6%2021-01-01 → 2021-12-31dStandaloneRate of return on equity (5-year summary)
ROE23.4%2020-01-01 → 2020-12-31dStandaloneRate of return on equity (5-year summary)
ROE17.3%2018-01-01 → 2018-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued130,010,400at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued130,010,400at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued130,010,400at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued125,910,400at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued125,310,400at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued125,310,400at 2018-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees153at 2023-12-31StandaloneNumber of employees
Employees155at 2022-12-31StandaloneNumber of employees
Employees141at 2021-12-31dStandaloneNumber of employees
Employees128at 2020-12-31dStandaloneNumber of employees
Employees107at 2019-12-31dStandaloneNumber of employees
Employees104at 2018-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 28
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-12-31−¥87m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-12-31−¥87m
Drug Discovery And Development Businessreportable segmentemployeesat 2023-12-31153 pure
Drug Discovery And Development Businessreportable segmentrevenue2023-01-01 → 2023-12-31¥12.7bn
Drug Discovery And Development Businessreportable segmentrevenue external2023-01-01 → 2023-12-31¥12.7bn
Drug Discovery And Development Businessreportable segmentsegment profit2023-01-01 → 2023-12-31¥6.4bn
Radiopharmaceuticals Businessreportable segmentemployeesat 2023-12-31450 pure
Radiopharmaceuticals Businessreportable segmentrevenue2023-01-01 → 2023-12-31¥16.1bn
Radiopharmaceuticals Businessreportable segmentrevenue external2023-01-01 → 2023-12-31¥16.0bn
Radiopharmaceuticals Businessreportable segmentrevenue intersegment2023-01-01 → 2023-12-31¥87m
Radiopharmaceuticals Businessreportable segmentsegment profit2023-01-01 → 2023-12-31¥475m
—segment totalrevenue2023-01-01 → 2023-12-31¥28.8bn
—segment totalrevenue external2023-01-01 → 2023-12-31¥28.7bn
—segment totalrevenue intersegment2023-01-01 → 2023-12-31¥87m
—segment totalsegment profit2023-01-01 → 2023-12-31¥6.9bn
Reconciling Itemsreconcilingrevenue2022-01-01 → 2022-12-31−¥27m
Reconciling Itemsreconcilingrevenue intersegment2022-01-01 → 2022-12-31−¥27m
Drug Discovery And Development Businessreportable segmentrevenue2022-01-01 → 2022-12-31¥15.4bn
Drug Discovery And Development Businessreportable segmentrevenue external2022-01-01 → 2022-12-31¥15.4bn
Drug Discovery And Development Businessreportable segmentsegment profit2022-01-01 → 2022-12-31¥9.2bn
Radiopharmaceuticals Businessreportable segmentrevenue2022-01-01 → 2022-12-31¥11.5bn
Radiopharmaceuticals Businessreportable segmentrevenue external2022-01-01 → 2022-12-31¥11.4bn
Radiopharmaceuticals Businessreportable segmentrevenue intersegment2022-01-01 → 2022-12-31¥27m
Radiopharmaceuticals Businessreportable segmentsegment profit2022-01-01 → 2022-12-31¥236m
—segment totalrevenue2022-01-01 → 2022-12-31¥26.9bn
—segment totalrevenue external2022-01-01 → 2022-12-31¥26.9bn
—segment totalrevenue intersegment2022-01-01 → 2022-12-31¥27m
—segment totalsegment profit2022-01-01 → 2022-12-31¥9.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,459
ItemContextValueUnit
Profit loss IFRSCurrentYearDuration3035832000JPY
Profit loss attributable to owners of parent IFRSPrior1YearDuration7554358000JPY
Profit loss attributable to owners of parent IFRSCurrentYearDuration3035832000JPY
Profit loss IFRSPrior1YearDuration7554358000JPY
Profit loss IFRSCurrentYearDuration3035832000JPY
Basic earnings loss per share IFRSPrior1YearDuration58.19
Basic earnings loss per share IFRSCurrentYearDuration23.41
Diluted earnings loss per share IFRSPrior1YearDuration58.14
Diluted earnings loss per share IFRSCurrentYearDuration23.38
Profit loss IFRSPrior1YearDuration7554358000JPY
Profit loss IFRSCurrentYearDuration3035832000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YearDuration-869301000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYearDuration5741157000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YearDuration-78707000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYearDuration-16470000JPY
Total of items that will not be reclassified to profit or loss oci IFRSPrior1YearDuration-948009000JPY
Total of items that will not be reclassified to profit or loss oci IFRSCurrentYearDuration5724687000JPY
Other comprehensive income IFRSPrior1YearDuration-948009000JPY
Other comprehensive income IFRSCurrentYearDuration5724687000JPY
Comprehensive income IFRSPrior1YearDuration6606348000JPY
Comprehensive income IFRSCurrentYearDuration8760519000JPY
Comprehensive income attributable to owners of parent IFRSPrior1YearDuration6606348000JPY
Comprehensive income attributable to owners of parent IFRSCurrentYearDuration8760519000JPY
Comprehensive income IFRSPrior1YearDuration6606348000JPY
Comprehensive income IFRSCurrentYearDuration8760519000JPY
Equity IFRSPrior2YearInstant_ShareCapitalIFRSMember3956738000JPY
Equity IFRSPrior2YearInstant_CapitalSurplusIFRSMember4452358000JPY
Equity IFRSPrior2YearInstant_TreasurySharesIFRSMember-620123000JPY
Equity IFRSPrior2YearInstant_RetainedEarningsIFRSMember16372687000JPY
Equity IFRSPrior2YearInstant_OtherComponentsOfEquityIFRSMember1188589000JPY
Equity IFRSPrior2YearInstant_EquityAttributableToOwnersOfParentIFRSMember25350250000JPY
Equity IFRSPrior2YearInstant25350250000JPY
Profit loss IFRSPrior1YearDuration_ShareCapitalIFRSMember－JPY
Profit loss IFRSPrior1YearDuration_CapitalSurplusIFRSMember－JPY
Profit loss IFRSPrior1YearDuration_TreasurySharesIFRSMember－JPY
Profit loss IFRSPrior1YearDuration_RetainedEarningsIFRSMember7554358000JPY
Profit loss IFRSPrior1YearDuration_OtherComponentsOfEquityIFRSMember－JPY
Profit loss IFRSPrior1YearDuration_EquityAttributableToOwnersOfParentIFRSMember7554358000JPY
Profit loss IFRSPrior1YearDuration7554358000JPY
Other comprehensive income IFRSPrior1YearDuration_ShareCapitalIFRSMember－JPY
Other comprehensive income IFRSPrior1YearDuration_CapitalSurplusIFRSMember－JPY
Other comprehensive income IFRSPrior1YearDuration_TreasurySharesIFRSMember－JPY
Other comprehensive income IFRSPrior1YearDuration_RetainedEarningsIFRSMember－JPY
Other comprehensive income IFRSPrior1YearDuration_OtherComponentsOfEquityIFRSMember-948009000JPY
Other comprehensive income IFRSPrior1YearDuration_EquityAttributableToOwnersOfParentIFRSMember-948009000JPY
Other comprehensive income IFRSPrior1YearDuration-948009000JPY
Comprehensive income IFRSPrior1YearDuration_ShareCapitalIFRSMember－JPY
Comprehensive income IFRSPrior1YearDuration_CapitalSurplusIFRSMember－JPY
Comprehensive income IFRSPrior1YearDuration_TreasurySharesIFRSMember－JPY
Comprehensive income IFRSPrior1YearDuration_RetainedEarningsIFRSMember7554358000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 18 of 22 passed
balance sheet identityconsolidated 2022-12-31pass rounding
balance sheet identityconsolidated 2023-12-31pass rounding
balance sheet identitynon_consolidated 2022-12-31pass rounding
balance sheet identitynon_consolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31mismatch
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-12-31mismatch
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-12-31mismatch
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2022-12-31mismatch
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass